<?xml version="1.0" encoding="UTF-8"?>
<p>There has been an accelerated paradigm shift towards iART both globally and in the US. While a recent global meta-analysis of iART studies emphasized that the strongest evidence supporting favorable HIV care outcomes comes from low- and middle-income countries, there have been no randomized controlled trials of iART programs in the US [
 <xref rid="B24-ijerph-17-07345" ref-type="bibr">24</xref>]. A clinic-based cohort study of San Francisco General Hospitalâ€™s Ward 86 RAPID model, the first noted iART program in the US, showed improved time to viral suppression and time to linkage to care with iART versus delayed ART [
 <xref rid="B15-ijerph-17-07345" ref-type="bibr">15</xref>]. About 95% of patients who underwent RAPID initiated ART the same day as HIV diagnosis and reached viral suppression at 1.8 months compared to non-RAPID patients who reached viral suppression at 4.3 months [
 <xref rid="B15-ijerph-17-07345" ref-type="bibr">15</xref>]. 
</p>
